These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14969331)

  • 1. Some pyridazinone and phthalazinone derivatives and their vasodilator activities.
    Demirayak S; Karaburun AC; Kayagil I; Erol K; Sirmagul B
    Arch Pharm Res; 2004 Jan; 27(1):13-8. PubMed ID: 14969331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some pyrrole substituted aryl pyridazinone and phthalazinone derivatives and their antihypertensive activities.
    Demirayak S; Karaburun AC; Beis R
    Eur J Med Chem; 2004 Dec; 39(12):1089-95. PubMed ID: 15571871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and vasodilatory activity of some amide derivatives of 6-(4-carboxymethyloxyphenyl)-4,5-dihydro-3(2H)-pyridazinone.
    Bansal R; Kumar D; Carron R; de la Calle C
    Eur J Med Chem; 2009 Nov; 44(11):4441-7. PubMed ID: 19589624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and vasodilator activity of some pyridazin-3(2
    Allam HA; Kamel AA; El-Daly M; George RF
    Future Med Chem; 2020 Jan; 12(1):37-50. PubMed ID: 31710239
    [No Abstract]   [Full Text] [Related]  

  • 5. Pyridazinone derivatives: design, synthesis, and in vitro vasorelaxant activity.
    Abouzid K; Abdel Hakeem M; Khalil O; Maklad Y
    Bioorg Med Chem; 2008 Jan; 16(1):382-9. PubMed ID: 17905589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiotonic agents. 9. Synthesis and biological evaluation of a series of (E)-4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]ethenyl]-3 (2H)-pyridazinones: a novel class of compounds with positive inotropic, antithrombotic, and vasodilatory activities for the treatment of congestive heart failure.
    Sircar I; Steffen RP; Bobowski G; Burke SE; Newton RS; Weishaar RE; Bristol JA; Evans DB
    J Med Chem; 1989 Feb; 32(2):342-50. PubMed ID: 2536438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization and antihypertensive activity of pyridazinone derivatives.
    Siddiqui AA; Mishra R; Shaharyar M
    Eur J Med Chem; 2010 Jun; 45(6):2283-90. PubMed ID: 20189270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and molecular modelling of pyridazinone and phthalazinone derivatives as protein kinases inhibitors.
    Elagawany M; Ibrahim MA; Ali Ahmed HE; El-Etrawy ASh; Ghiaty A; Abdel-Samii ZK; El-Feky SA; Bajorath J
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2007-13. PubMed ID: 23453843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 7-(Ethoxycarbonyl)-6,8-dimethyl-2-phenyl-1(2H)-phthalazinone derivatives: synthesis and inhibitory effects on platelet aggregation.
    Sugimoto A; Tanaka H; Eguchi Y; Ito S; Takashima Y; Ishikawa M
    J Med Chem; 1984 Oct; 27(10):1300-5. PubMed ID: 6090662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activity of the four stereoisomers of 6-[4-[3-[[2-hydroxy-3-[4-[2- (cyclopropylmethoxy)ethyl]phenoxy]propyl]amino]-propionamido] phenyl]-5-methyl-4,5-dihydro-3(2H)-pyridazinone, a combined vasodilator and beta-adrenoceptor antagonist.
    Howson W; Kitteringham J; Mistry J; Mitchell MB; Novelli R; Slater RA; Swayne GT
    J Med Chem; 1988 Feb; 31(2):352-6. PubMed ID: 2892935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of 2-substituted-6-phenyl-4,5-dihydropyridazin-3(2H)-ones as potent inodilators.
    Kumar D; Carron R; La Calle CD; Jindal DP; Bansal R
    Acta Pharm; 2008 Dec; 58(4):393-405. PubMed ID: 19103574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on agents with vasodilator and beta-blocking activities. IV.
    Seki T; Nakao T; Masuda T; Hasumi K; Gotanda K; Ishimori T; Honma S; Minami N; Shibata K; Yasuda K
    Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2061-9. PubMed ID: 8945771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and selective coronary vasodilatory activity of 3,4-dihydro-2,2-bis(methoxymethyl)-2H-1-benzopyran-3-ol derivatives: novel potassium channel openers.
    Cho H; Katoh S; Sayama S; Murakami K; Nakanishi H; Kajimoto Y; Ueno H; Kawasaki H; Aisaka K; Uchida I
    J Med Chem; 1996 Sep; 39(19):3797-805. PubMed ID: 8809167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal and molecular structures of pyridazinone cardiovascular agents.
    Prout K; Bannister C; Burns K; Chen M; Warrington BH; Vinter JG
    Acta Crystallogr B; 1994 Feb; 50 ( Pt 1)():71-85. PubMed ID: 8148097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on agents with vasodilator and beta-blocking activities. I.
    Seki T; Takezaki T; Ohuchi R; Ohuyabu H; Ishimori T; Yasuda K
    Chem Pharm Bull (Tokyo); 1994 Aug; 42(8):1609-16. PubMed ID: 7954913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and structure-activity relationship studies of 6-phenyl-4,5-dihydro-3(2H)-pyridazinone derivatives as cardiotonic agents.
    Wang T; Dong Y; Wang LC; Xiang BR; Chen Z; Qu LB
    Arzneimittelforschung; 2008; 58(11):569-73. PubMed ID: 19137907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. 1. 2-[2-(1-Imidazolyl)alkyl]-1(2H)-phthalazinones.
    Yamaguchi M; Kamei K; Koga T; Akima M; Kuroki T; Ohi N
    J Med Chem; 1993 Dec; 36(25):4052-60. PubMed ID: 8258827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and bioactivity of 6-phenyl-4,5-dihydro-3(2H)-pyridazinone derivatives.
    Wang T; Dong Y; Wang LC; Chen Z
    Arzneimittelforschung; 2007; 57(10):641-6. PubMed ID: 18074757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of a series of combined vasodilator/beta-adrenoceptor antagonists based on 6-arylpyridazinones.
    Slater RA; Howson W; Swayne GT; Taylor EM; Reavill DR
    J Med Chem; 1988 Feb; 31(2):345-51. PubMed ID: 2892934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and inhibitory effect on platelet aggregation of 2-phenyl-1(2H)-phthalazinone derivatives.
    Sugimoto A; Sakamoto K; Fujino Y; Takashima Y; Ishikawa M
    Chem Pharm Bull (Tokyo); 1985 Jul; 33(7):2809-20. PubMed ID: 4085040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.